Patent · US Active

Nanolipogel vehicles for controlled delivery of different pharmaceutical agents

US9610250B2 · kind B2 · utility

5Cited by
13References
48Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 12, 2013
Grant dateApr 4, 2017
Priority date
Expiry dateApr 12, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/2812
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A “nanolipogel” is a delivery vehicle including one or more lipid layer surrounding a hydrogel core, which may include an absorbent such as a cyclodextrin or ion-exchange resin. Nanolipogels can be constructed so as to incorporate a variety of different chemical entities that can subsequently be released in a controlled fashion. These different incorporated chemical entities can differ dramatically with respect to size and composition. Nanolipogels have been constructed to contain co-encapsulated proteins as well as small hydrophobic drugs within the interior of the lipid bilayer. Agents incorporated within nanolipogels can be released into the milieu in a controlled fashion, for example, nanolipogels provide a means of achieving simultaneous sustained release of agents that differ widely in chemical composition and molecular weight. Additionally, nanolipogels can favorably modulate biodistribution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.